Free Trial

MeiraGTx (MGTX) Competitors

MeiraGTx logo
$8.62 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$8.62 0.00 (0.00%)
As of 04:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MGTX vs. IBRX, GMTX, ARWR, APLS, TWST, NAMS, APGE, RXRX, DNLI, and INDV

Should you be buying MeiraGTx stock or one of its competitors? The main competitors of MeiraGTx include ImmunityBio (IBRX), Gemini Therapeutics (GMTX), Arrowhead Pharmaceuticals (ARWR), Apellis Pharmaceuticals (APLS), Twist Bioscience (TWST), NewAmsterdam Pharma (NAMS), Apogee Therapeutics (APGE), Recursion Pharmaceuticals (RXRX), Denali Therapeutics (DNLI), and Indivior (INDV). These companies are all part of the "pharmaceutical products" industry.

MeiraGTx vs. Its Competitors

MeiraGTx (NASDAQ:MGTX) and ImmunityBio (NASDAQ:IBRX) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, risk, dividends, profitability, analyst recommendations, earnings and valuation.

MeiraGTx has a net margin of -484.90% compared to ImmunityBio's net margin of -1,310.30%. ImmunityBio's return on equity of 0.00% beat MeiraGTx's return on equity.

Company Net Margins Return on Equity Return on Assets
MeiraGTx-484.90% -241.05% -62.93%
ImmunityBio -1,310.30%N/A -121.88%

In the previous week, MeiraGTx and MeiraGTx both had 1 articles in the media. ImmunityBio's average media sentiment score of 0.88 beat MeiraGTx's score of 0.74 indicating that ImmunityBio is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MeiraGTx
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
ImmunityBio
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

MeiraGTx has a beta of 1.24, meaning that its share price is 24% more volatile than the S&P 500. Comparatively, ImmunityBio has a beta of 0.08, meaning that its share price is 92% less volatile than the S&P 500.

MeiraGTx presently has a consensus price target of $24.00, suggesting a potential upside of 178.42%. ImmunityBio has a consensus price target of $12.25, suggesting a potential upside of 345.45%. Given ImmunityBio's stronger consensus rating and higher possible upside, analysts plainly believe ImmunityBio is more favorable than MeiraGTx.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MeiraGTx
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
ImmunityBio
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20

67.5% of MeiraGTx shares are owned by institutional investors. Comparatively, 8.6% of ImmunityBio shares are owned by institutional investors. 7.5% of MeiraGTx shares are owned by company insiders. Comparatively, 76.8% of ImmunityBio shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

MeiraGTx has higher revenue and earnings than ImmunityBio. ImmunityBio is trading at a lower price-to-earnings ratio than MeiraGTx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MeiraGTx$33.28M20.81-$147.79M-$2.32-3.72
ImmunityBio$14.74M164.67-$413.56M-$0.58-4.74

Summary

ImmunityBio beats MeiraGTx on 9 of the 16 factors compared between the two stocks.

Get MeiraGTx News Delivered to You Automatically

Sign up to receive the latest news and ratings for MGTX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MGTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MGTX vs. The Competition

MetricMeiraGTxMED IndustryMedical SectorNASDAQ Exchange
Market Cap$692.75M$2.96B$5.54B$9.41B
Dividend YieldN/A2.46%3.75%4.03%
P/E Ratio-3.728.2821.0120.09
Price / Sales20.81303.17433.8199.01
Price / CashN/A42.5936.1658.27
Price / Book9.917.678.125.65
Net Income-$147.79M-$55.28M$3.25B$257.91M
7 Day Performance1.77%2.50%0.97%2.09%
1 Month Performance33.02%11.70%7.36%11.13%
1 Year Performance84.58%4.89%31.31%18.40%

MeiraGTx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MGTX
MeiraGTx
4.1746 of 5 stars
$8.62
flat
$24.00
+178.4%
+72.7%$692.75M$33.28M-3.72300
IBRX
ImmunityBio
2.2868 of 5 stars
$2.72
flat
$12.25
+350.4%
-53.8%$2.40B$14.74M-4.69590Gap Up
GMTX
Gemini Therapeutics
N/A$54.75
+3.0%
N/A+19.7%$2.37BN/A-54.7530
ARWR
Arrowhead Pharmaceuticals
3.8607 of 5 stars
$16.84
+0.3%
$43.71
+159.6%
-32.7%$2.32B$3.55M-12.03400News Coverage
Positive News
APLS
Apellis Pharmaceuticals
4.3305 of 5 stars
$17.42
-4.6%
$39.79
+128.4%
-49.3%$2.29B$781.37M-9.73770Trending News
Analyst Forecast
Insider Trade
Analyst Revision
TWST
Twist Bioscience
4.227 of 5 stars
$35.59
-6.8%
$50.40
+41.6%
-36.2%$2.29B$312.97M-10.95990News Coverage
NAMS
NewAmsterdam Pharma
3.5952 of 5 stars
$19.46
-2.0%
$42.89
+120.4%
+16.9%$2.23B$45.56M-10.354News Coverage
Analyst Forecast
Insider Trade
APGE
Apogee Therapeutics
3.0043 of 5 stars
$39.24
-17.3%
$99.00
+152.3%
-20.7%$2.19BN/A-10.9091High Trading Volume
RXRX
Recursion Pharmaceuticals
1.1335 of 5 stars
$4.93
-6.5%
$7.00
+42.0%
-33.9%$2.14B$58.84M-2.79400Gap Up
High Trading Volume
DNLI
Denali Therapeutics
4.537 of 5 stars
$14.25
-3.0%
$33.71
+136.6%
-36.9%$2.13B$330.53M-5.34430
INDV
Indivior
1.3487 of 5 stars
$15.55
+0.9%
$17.00
+9.3%
+50.0%$2.12B$1.17B-50.161,051Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:MGTX) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners